TY - JOUR
T1 - Availability and financing of CAR-T cell therapies: A cross-country comparative analysis
AU - Litvinova, Yulia
AU - Merkur, Sherry
AU - Allin, Sara
AU - Angulo-Pueyo, Ester
AU - Behmane, Daiga
AU - Bernal-Delgado, Enrique
AU - Dalmas, Miriam
AU - De Belvis, Antonio
AU - Edwards, Nigel
AU - Estupiñán-Romero, Francisco
AU - Gaal, Peter
AU - Gerkens, Sophie
AU - Jamieson, Margaret
AU - Morsella, Alisha
AU - Picecchi, Dario
AU - Røshol, Hilde
AU - Saunes, Ingrid Sperre
AU - Sullivan, Terry
AU - Szécsényi-Nagy, Balázs
AU - Vijver, Inneke Van De
AU - Walter, Ricciardi
AU - Panteli, Dimitra
PY - 2024
Y1 - 2024
KW - Advanced Therapy Medicinal Products (ATMPs)
KW - Cancer, Pharmaceutical policy
KW - Chimeric antigen receptor (CAR) T-cell therapies
KW - Oncology care
KW - Advanced Therapy Medicinal Products (ATMPs)
KW - Cancer, Pharmaceutical policy
KW - Chimeric antigen receptor (CAR) T-cell therapies
KW - Oncology care
UR - http://hdl.handle.net/10807/291616
U2 - 10.1016/j.healthpol.2024.105153
DO - 10.1016/j.healthpol.2024.105153
M3 - Article
SN - 0168-8510
VL - 149
SP - 1
EP - 9
JO - Health Policy
JF - Health Policy
ER -